(READ) Watchdogs want FDA to reject fast-tracking of new gene therapy treatment
Public Citizen’s Health Research Group wants the FDA to deny speeded up approval of a new gene therapy treatment. The advocacy group states that the treatment, SRP-9001 (Sarepta Therapeutics) for ambulatory Duchenne muscular dystrophy (DMD), intended for children aged four […]
(READ) Watchdogs want FDA to reject fast-tracking of new gene therapy treatment Read More »
